Cargando…
Is Intrinsic Cardioprotection a Laboratory Phenomenon or a Clinically Relevant Tool to Salvage the Failing Heart?
Cardiovascular diseases, especially ischemic heart disease, as a leading cause of heart failure (HF) and mortality, will not reduce over the coming decades despite the progress in pharmacotherapy, interventional cardiology, and surgery. Although patients surviving acute myocardial infarction live lo...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671596/ https://www.ncbi.nlm.nih.gov/pubmed/38003687 http://dx.doi.org/10.3390/ijms242216497 |
_version_ | 1785149435161870336 |
---|---|
author | Ravingerova, Tanya Adameova, Adriana Lonek, Lubomir Farkasova, Veronika Ferko, Miroslav Andelova, Natalia Kura, Branislav Slezak, Jan Galatou, Eleftheria Lazou, Antigone Zohdi, Vladislava Dhalla, Naranjan S. |
author_facet | Ravingerova, Tanya Adameova, Adriana Lonek, Lubomir Farkasova, Veronika Ferko, Miroslav Andelova, Natalia Kura, Branislav Slezak, Jan Galatou, Eleftheria Lazou, Antigone Zohdi, Vladislava Dhalla, Naranjan S. |
author_sort | Ravingerova, Tanya |
collection | PubMed |
description | Cardiovascular diseases, especially ischemic heart disease, as a leading cause of heart failure (HF) and mortality, will not reduce over the coming decades despite the progress in pharmacotherapy, interventional cardiology, and surgery. Although patients surviving acute myocardial infarction live longer, alteration of heart function will later lead to HF. Its rising incidence represents a danger, especially among the elderly, with data showing more unfavorable results among females than among males. Experiments revealed an infarct-sparing effect of ischemic “preconditioning” (IPC) as the most robust form of innate cardioprotection based on the heart’s adaptation to moderate stress, increasing its resistance to severe insults. However, translation to clinical practice is limited by technical requirements and limited time. Novel forms of adaptive interventions, such as “remote” IPC, have already been applied in patients, albeit with different effectiveness. Cardiac ischemic tolerance can also be increased by other noninvasive approaches, such as adaptation to hypoxia- or exercise-induced preconditioning. Although their molecular mechanisms are not yet fully understood, some noninvasive modalities appear to be promising novel strategies for fighting HF through targeting its numerous mechanisms. In this review, we will discuss the molecular mechanisms of heart injury and repair, as well as interventions that have potential to be used in the treatment of patients. |
format | Online Article Text |
id | pubmed-10671596 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106715962023-11-18 Is Intrinsic Cardioprotection a Laboratory Phenomenon or a Clinically Relevant Tool to Salvage the Failing Heart? Ravingerova, Tanya Adameova, Adriana Lonek, Lubomir Farkasova, Veronika Ferko, Miroslav Andelova, Natalia Kura, Branislav Slezak, Jan Galatou, Eleftheria Lazou, Antigone Zohdi, Vladislava Dhalla, Naranjan S. Int J Mol Sci Review Cardiovascular diseases, especially ischemic heart disease, as a leading cause of heart failure (HF) and mortality, will not reduce over the coming decades despite the progress in pharmacotherapy, interventional cardiology, and surgery. Although patients surviving acute myocardial infarction live longer, alteration of heart function will later lead to HF. Its rising incidence represents a danger, especially among the elderly, with data showing more unfavorable results among females than among males. Experiments revealed an infarct-sparing effect of ischemic “preconditioning” (IPC) as the most robust form of innate cardioprotection based on the heart’s adaptation to moderate stress, increasing its resistance to severe insults. However, translation to clinical practice is limited by technical requirements and limited time. Novel forms of adaptive interventions, such as “remote” IPC, have already been applied in patients, albeit with different effectiveness. Cardiac ischemic tolerance can also be increased by other noninvasive approaches, such as adaptation to hypoxia- or exercise-induced preconditioning. Although their molecular mechanisms are not yet fully understood, some noninvasive modalities appear to be promising novel strategies for fighting HF through targeting its numerous mechanisms. In this review, we will discuss the molecular mechanisms of heart injury and repair, as well as interventions that have potential to be used in the treatment of patients. MDPI 2023-11-18 /pmc/articles/PMC10671596/ /pubmed/38003687 http://dx.doi.org/10.3390/ijms242216497 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ravingerova, Tanya Adameova, Adriana Lonek, Lubomir Farkasova, Veronika Ferko, Miroslav Andelova, Natalia Kura, Branislav Slezak, Jan Galatou, Eleftheria Lazou, Antigone Zohdi, Vladislava Dhalla, Naranjan S. Is Intrinsic Cardioprotection a Laboratory Phenomenon or a Clinically Relevant Tool to Salvage the Failing Heart? |
title | Is Intrinsic Cardioprotection a Laboratory Phenomenon or a Clinically Relevant Tool to Salvage the Failing Heart? |
title_full | Is Intrinsic Cardioprotection a Laboratory Phenomenon or a Clinically Relevant Tool to Salvage the Failing Heart? |
title_fullStr | Is Intrinsic Cardioprotection a Laboratory Phenomenon or a Clinically Relevant Tool to Salvage the Failing Heart? |
title_full_unstemmed | Is Intrinsic Cardioprotection a Laboratory Phenomenon or a Clinically Relevant Tool to Salvage the Failing Heart? |
title_short | Is Intrinsic Cardioprotection a Laboratory Phenomenon or a Clinically Relevant Tool to Salvage the Failing Heart? |
title_sort | is intrinsic cardioprotection a laboratory phenomenon or a clinically relevant tool to salvage the failing heart? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671596/ https://www.ncbi.nlm.nih.gov/pubmed/38003687 http://dx.doi.org/10.3390/ijms242216497 |
work_keys_str_mv | AT ravingerovatanya isintrinsiccardioprotectionalaboratoryphenomenonoraclinicallyrelevanttooltosalvagethefailingheart AT adameovaadriana isintrinsiccardioprotectionalaboratoryphenomenonoraclinicallyrelevanttooltosalvagethefailingheart AT loneklubomir isintrinsiccardioprotectionalaboratoryphenomenonoraclinicallyrelevanttooltosalvagethefailingheart AT farkasovaveronika isintrinsiccardioprotectionalaboratoryphenomenonoraclinicallyrelevanttooltosalvagethefailingheart AT ferkomiroslav isintrinsiccardioprotectionalaboratoryphenomenonoraclinicallyrelevanttooltosalvagethefailingheart AT andelovanatalia isintrinsiccardioprotectionalaboratoryphenomenonoraclinicallyrelevanttooltosalvagethefailingheart AT kurabranislav isintrinsiccardioprotectionalaboratoryphenomenonoraclinicallyrelevanttooltosalvagethefailingheart AT slezakjan isintrinsiccardioprotectionalaboratoryphenomenonoraclinicallyrelevanttooltosalvagethefailingheart AT galatoueleftheria isintrinsiccardioprotectionalaboratoryphenomenonoraclinicallyrelevanttooltosalvagethefailingheart AT lazouantigone isintrinsiccardioprotectionalaboratoryphenomenonoraclinicallyrelevanttooltosalvagethefailingheart AT zohdivladislava isintrinsiccardioprotectionalaboratoryphenomenonoraclinicallyrelevanttooltosalvagethefailingheart AT dhallanaranjans isintrinsiccardioprotectionalaboratoryphenomenonoraclinicallyrelevanttooltosalvagethefailingheart |